The liquid biopsy: a tool for a combined diagnostic and theranostic approach for care of a patient with late-stage lung carcinoma presenting with bilateral ocular metastases

Expert Review of Anticancer Therapy
Linda BouhlelPaul Hofman

Abstract

Liquid biopsies (LB) are used routinely in clinical practice in two situations for late stage non-small-cell lung cancer (NSCLC) patients, (i) at the initial diagnosis when looking for activating mutations in EGFR in the absence of analyzable tissue DNA and, (ii) during tumor progression on a tyrosine kinase inhibitor treatment to look for the resistance mutation T790M in EGFR. LB is not presently recommended in daily practice for the diagnosis of NSCLC. Areas covered: We report the diagnosis of a NSCLC in a patient with bilateral ocular metastases after detection of a deletion in exon 19 of EGFR when using plasma DNA. Without histological analysis, the origin of the primary ocular metastasis was uncertain. In this context, a LB showing an activating mutation in EGFR and circulating tumor cells positive for TTF1 led to the diagnosis of NSCLC and targeted therapy. Expert commentary: When no tumor tissue sample is available a LB can be used to diagnose for metastatic NSCLC, when a mutation in EGFR is identified. While a tissue biopsy is the gold standard approach for the diagnosis of a NSCLC and for identification of activating mutations, LB can exceptionally provide both a diagnosis of the primitive tumor and indicate appropriat...Continue Reading

References

Jul 22, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eunice L KwakDaphne W Bell
Nov 26, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Véronique HofmanPaul Hofman
Dec 17, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Matthew G KrebsCaroline Dive
May 17, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Geoffrey R OxnardMaria E Arcila
Jun 28, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M IlieP Hofman
Dec 24, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ayako FujiwaraIsamu Okamoto
Aug 15, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jean-Yves DouillardRose McCormack
Dec 3, 2014·Cancer Treatment Reviews·P JardelJ Thariat
Nov 21, 2015·Cancer Cytopathology·Véronique J HofmanPaul M Hofman
Jun 30, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Geoffrey R OxnardPasi A Jänne
Aug 25, 2016·Virchows Archiv : an International Journal of Pathology·Paul Hofman, Helmut H Popper
Sep 24, 2016·Translational Lung Cancer Research·Marius Ilié, Paul Hofman
Nov 9, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sonya Parpart-LiLuis A Diaz
Dec 3, 2016·Current Opinion in Oncology·Paul Hofman
Jan 19, 2017·Oncotarget·Wei-Lun HuangChien-Chung Lin
Jan 28, 2017·Current Opinion in Genetics & Development·Timothy M ButlerJoe Gray
Jan 29, 2017·Expert Review of Molecular Diagnostics·Umberto MalapelleCarlos Camps
Feb 27, 2017·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·David MaskellThankamma Ajithkumar
Mar 24, 2017·Biological Procedures Online·Yan LuLing/L Xu
Jun 14, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Reyes BernabéFiona Helen Blackhall
Jun 15, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Adrian G SacherGeoffrey R Oxnard
Jul 26, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Christophe MassardJean-Charles Soria
Aug 2, 2017·Annals of Translational Medicine·Linda KöhnJonas Nilsson
Aug 18, 2017·Science Translational Medicine·Jillian PhallenVictor E Velculescu
Nov 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M IlieP Hofman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Related Papers

Expert Opinion on Therapeutic Targets
Nicola NormannoAntonella De Luca
Journal of Neuro-oncology
Fanny Burel-VandenbosFlorence Pedeutour
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Audrey ValléeMarc G Denis
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Surein ArulanandaThomas John
© 2022 Meta ULC. All rights reserved